United States

This archive collects solutions-journalism stories and milestones from the United States — covering policy wins, community-led efforts, scientific advances, and social progress happening across the country. Each entry highlights what’s working and why it matters.

"Do not cross police barricade" tape, for article on U.S. homicide decline

Homicides in the U.S. see historic decline in 2023

Violent crime across America fell at one of the fastest rates ever recorded in 2023, offering a meaningful reversal after the pandemic years pushed homicides to historic highs. The drop touched cities of nearly every size — from large metros like Los Angeles and Chicago to suburban and rural counties alike. Analysts were surprised by both the speed and the breadth of the turnaround. Progress like this shows that even deeply entrenched crime surges can reverse, giving communities and policymakers reason to believe that coordinated, sustained effort genuinely moves the needle.

Industrial pipes and infrastructure at a coastal energy facility for an article about carbon capture and storage, for article on fusion plasma record, for article on fusion plasma record, for article on fusion endurance record, for article on nuclear fusion ignition

American scientists repeatedly produce nuclear fusion ignition for the first time in history

Nuclear fusion just cleared a crucial bar: scientists at California’s Lawrence Livermore National Laboratory have now achieved ignition four separate times, with the best shot producing 89 percent more energy than the lasers delivered to the target. That repetition is what transforms a single 2022 breakthrough into real, replicable science — proof that the Sun-like reaction can be coaxed out of a frozen hydrogen pellet on Earth, again and again. Momentum is building beyond the lab, too, with more than $6 billion now invested in fusion worldwide and governments at COP28 agreeing to speed things along. The road from a boiled kettle’s worth of energy to a clean-powered grid is still long, but the hardest physics is finally behind us.

Depiction of MRSA bacteria up close, for article on MRSA antibiotic discovery

MIT scientists discover the first new antibiotics in over 60 years using AI

A new class of antibiotics has been discovered for the first time in more than 60 years, and artificial intelligence helped get us there. MIT researchers trained deep-learning models to sift through roughly 12 million chemical compounds, eventually landing on two promising candidates that each cut MRSA populations tenfold in mouse studies. Just as importantly, the team built their AI to be transparent, so scientists can actually see why certain molecules work. That matters because the same framework could be turned loose on other drug-resistant infections, offering real hope against superbugs that kill tens of thousands of people every year.

Air pollution from industrial faciliity

MIT scientists discover how to convert CO2 into powder that can be stored for decades

Researchers at the Massachusetts Institute of Technology exposed CO2 to catalysts and then electrolysis that turns the gas into a powder called sodium formate, which can be safely stored for decades. The breakthrough follows an almost century-long effort to turn CO2 into a cheap, clean fuel. Researchers have previously turned CO2 into fuels that required too much energy to make or were difficult to store long-term.

Mail-in ballot with pen

Colorado to be first state in the U.S. to expand automatic voter registration to tribes

Tribal communities in Colorado share some of the same registration and voting barriers as other rural communities across the U.S., like geographic isolation and unreliable mail delivery. But according to the Native American Rights Fund, tribal communities also commonly experience obstacles like language barriers, a lack of voter registration opportunities, and state laws in some parts of the country that block polling places on tribal lands.

Self-portrait of a woman with cancer and her children, for article on triple-negative breast cancer vaccine

Triple-negative breast cancer vaccine shows good response in first clinical trial of patients

A new breast cancer vaccine sparked an immune response in three out of four patients during its first human safety trial — with no serious side effects reported. The Cleveland Clinic study targeted triple-negative breast cancer, an aggressive subtype that resists most standard treatments and disproportionately affects younger women and Black women. The vaccine works by training the immune system to recognize a lactation protein found in most TNBC tumors but absent in healthy adult tissue, giving immune cells a clear target. Next come larger trials testing whether it can prevent recurrence and even attack active tumors. It’s an early but hopeful signal in the growing field of cancer immunotherapy, where teaching the body to find cancer itself is reshaping what treatment can look like.